Oliver A Kent

Affiliations: 
University of Toronto, Toronto, ON, Canada 
Google:
"Oliver Kent"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kent OA, Saha M, Coyaud E, et al. (2020) Haploinsufficiency of RREB1 causes a Noonan-like RASopathy via epigenetic reprogramming of RAS-MAPK pathway genes. Nature Communications. 11: 4673
Grewal CS, Kent OA, MacMillan AM. (2017) Radical Probing of Spliceosome Assembly. Methods (San Diego, Calif.)
Kent OA, Sandi MJ, Rottapel R. (2017) Co-dependency between KRAS addiction and ARHGEF2 promotes an adaptive escape from MAPK pathway inhibition. Small Gtpases. 10: 441-448
Matsumoto Y, Larose J, Kent OA, et al. (2017) RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146. The Journal of Clinical Investigation
Kent OA, Sandí MJ, Burston HE, et al. (2016) An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer. Oncotarget
Matsumoto Y, La Rose J, Kent OA, et al. (2016) Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2. The Journal of Clinical Investigation
Kent OA, Mendell JT, Rottapel R. (2016) Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1. Molecular Cancer Research : McR. 14: 267-77
Cullis J, Meiri D, Sandi MJ, et al. (2014) The RhoGEF GEF-H1 is required for oncogenic RAS signaling via KSR-1. Cancer Cell. 25: 181-95
Chaulk SG, Thede GL, Kent OA, et al. (2011) Role of pri-miRNA tertiary structure in miR-17~92 miRNA biogenesis. Rna Biology. 8: 1105-14
Kent OA, Macmillan AM. (2008) Proteins specifically modified with a chemical nuclease as probes of RNA-protein interaction. Methods in Molecular Biology (Clifton, N.J.). 488: 191-200
See more...